Director, International Hta Strategy, Immunology

Job Description
Advances in scientific and technological research are opening up new, promising treatments for previously difficult to treat diseases, increasing the demand on already constrained healthcare budgets. The challenging economic and political environment is leading Health Technology Assessment (HTA) agencies and payers to demand better outcomes at lower cost to overall health system.
To succeed in this environment, we (AbbVie) need to fully understand market value drivers, identify the evidence required for Pricing, Reimbursement and Access (PRA), and work with the evidence generating functions to ensure that evidence generated will support successful HTA outcome and PRA negotiations.
The Global HTA Strategy team is a international function within the International Market Access &
Pricing (IMAP) department. The team was established to realize the full value of our assets by strategically informing drug development, evidence generation and HTA submissions, aligned with HTA/payer needs. The primary goals of the function are to ensure HTA evidence requirements are considered early in the development of Abbvie assets and a robust and aligned HTA strategy across the organization in order to ensure the successful launch of Abbvie assets.
Key objective of role:
The International HTA Strategy head Immunology will drive strategy and process to ensure positive HTA outcome aligned with the Access ambition and strategy optimizing price, time to reimbursement and level of access for Immunology.
Key responsibilities:
Lead the Immunology HTA strategy team developing the Asset and indication HTA strategy in close collaboration with the internal cross-functional teams and external stakeholders
Oversees HTA strategy activities related to the team led HTA scientific advice strategy and execution in collaboration with large affiliates
Oversees team led and leads early affiliate engagement (Early Touchpoint process) on behalf of IMAP to help inform (registrational) clinical develop programs
Oversees team led and leads the development of the international HTA strategic guidance to support areas/affiliates on local HTA submissions.
Coordination across evidence generation functions at global level (Medical Affairs, HEOR and Clinical Development) to answer questions from HTA agencies
Oversees team led and Develops HTA insights collaborating with key affiliates to understand Access Evidence requirements for specific diseases and assets
Consult HTA decision Databases, develop HTA /payer engagement plans and gather insights from early scientific advice from HTA agencies and other external experts
Assess Target Product Profiles, Clinical Development Plans and inform Global Integrated Evidence Strategies
Provide strategic input into global development Programs, developing solutions and scenarios through the Asset Integrated Evidence Strategy Team.
Internal stakeholders include:
VP Immunology, International Market Access and Pricing;
Global Health Economicsand Outcomes Research;
Affiliates;
Areas;
R&
D;
Commercial;
Medical and Regulatory;
Governance bodies
Ensure clear lines of communication on progress and issues with the internal team, including senior management and supporting the team with the preparation of HTA-HEOR business reviews
Support the development of the HTA strategy Immunology team members
Monitoring evolving HTA technical and evidentiary requirements and shaping new methods with external partners